Lower urinary tract symptoms in patients with Parkinson’s Disease: findings from a Tunisian cohort
Objective: To assess lower urinary tract symptoms (LUTS) in patients with Parkinson’s disease (PD) and to investigate their impact on the quality of Life (QoL).…Effects of education level on motor and non-motor symptoms of Brazilian patients with Parkinson’s disease.
Objective: To investigate the influence of education level (EL) on motor and non-motor aspects of Parkinson’s disease (PD) in a Brazilian sample. Background: Only 30%…The impact of Parkinson’s disease on faith and spirituality
Objective: The objective of the present study is to assess the impact of Parkinson’s disease on faith and spirituality. Background: There are some controversies on…A new aroma in the new world
Objective: Investigate if olfactory impairment in PD patients are related with other non motor symptoms Background: Non motor symptoms (NMS) can precede Parkinson's Disease (PD)…Comparison of the non-motor symptom assessment scale between LRRK2 G2019S positive versus matched control Parkinson disease
Objective: To compare the non-motor symptom assessment scale (NMSS) score between Leucine-rich repeat kinase 2 (LRRK2) mutation carriers with Parkinson disease (PD) and matched controls with…Real-world non-motor score changes in Parkinson’s disease patients with motor fluctuations: The J-FIRST study
Objective: To identify changes in non-motor symptoms (NMSs) over time in Japanese Parkinson’s disease (PD) patients without dementia exhibiting motor fluctuations. Background: PD can cause…Parkinson’s Disease from the Patient Perspective
Objective: The purpose of this study was to describe the constellation of parkinsonian symptoms, as experienced by the patient. Background: For 200 years, the cardinal…Systematic Evaluation of Major and Minor Psychotic Symptoms in Parkinson’s Disease
Objective: To evaluate a structured clinical interview (SCI) based on the Parkinson’s disease-specific Scale for the Assessment of Positive Symptoms (SAPS-PD) in the identification of…Comorbidity and Parkinson’s disease phenotype, dopaminergic function and CSF biomarkers
Objective: To evaluate the influence of comorbidity on clinical phenotype, dopaminergic function and CSF biomarkers in a population of de novo Parkinson's disease (PD) patients.…The non-motors symptoms in Parkinson’s disease patients with freezing of gait
Objective: To reveal the prevalence of the non-motors symptoms and clinical features differences between Parkinson's disease (PD) patients with and without freezing of gait (FOG).…
- « Previous Page
- 1
- …
- 42
- 43
- 44
- 45
- 46
- …
- 51
- Next Page »